rs12232959

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_015702.3(MMADHC):​c.479-22G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000712 in 1,404,870 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.1e-7 ( 0 hom. )

Consequence

MMADHC
NM_015702.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.14

Publications

8 publications found
Variant links:
Genes affected
MMADHC (HGNC:25221): (metabolism of cobalamin associated D) This gene encodes a mitochondrial protein that is involved in an early step of vitamin B12 metabolism. Vitamin B12 (cobalamin) is essential for normal development and survival in humans. Mutations in this gene cause methylmalonic aciduria and homocystinuria type cblD (MMADHC), a disorder of cobalamin metabolism that is characterized by decreased levels of the coenzymes adenosylcobalamin and methylcobalamin. Pseudogenes have been identified on chromosomes 11 and X.[provided by RefSeq, Nov 2008]
MMADHC Gene-Disease associations (from GenCC):
  • inborn disorder of cobalamin metabolism and transport
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • methylmalonic aciduria and homocystinuria type cblD
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMADHCNM_015702.3 linkc.479-22G>T intron_variant Intron 5 of 7 ENST00000303319.10 NP_056517.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMADHCENST00000303319.10 linkc.479-22G>T intron_variant Intron 5 of 7 1 NM_015702.3 ENSP00000301920.5
MMADHCENST00000422782.2 linkc.479-22G>T intron_variant Intron 5 of 8 5 ENSP00000408331.2
MMADHCENST00000428879.5 linkc.479-22G>T intron_variant Intron 4 of 6 2 ENSP00000389060.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
7.12e-7
AC:
1
AN:
1404870
Hom.:
0
Cov.:
24
AF XY:
0.00000143
AC XY:
1
AN XY:
699186
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32398
American (AMR)
AF:
0.00
AC:
0
AN:
42156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25002
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38990
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52028
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5586
European-Non Finnish (NFE)
AF:
9.36e-7
AC:
1
AN:
1068650
Other (OTH)
AF:
0.00
AC:
0
AN:
58258
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
5319

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.81
DANN
Benign
0.59
PhyloP100
-2.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12232959; hg19: chr2-150432377; API